Access Vascular, Inc.

Access Vascular is offering a suite of vascular access devices that use our novel, patented biomaterial featuring MIMIX™ technology which is designed to prevent the most common and costly complications in vascular access. Keep treatment moving forward with products that have demonstrated in clinical, in vivo and in vitro data to have a statistically significant reduction in complications compared to standard polyurethane catheters. Tackle most avoidable complications like occlusions and replacements - no coatings, fillers or surface modifications. Provide better patient experience - fewer device replacements means fewer unnecessary needle sticks and fewer delays in treatment. Potentially save up to 50% material costs over standard polyurethane catheters with reduced complications.